Importance of Clean-in-Place Design Planning Emphasized - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Importance of Clean-in-Place Design Planning Emphasized


INTERPHEX Show Daily

Untitled Document

Interphex2007, New York, NY (Apr. 25)—As manufacturers prepare for processing more-potent compounds, they seek effective clean-in-place (CIP) and wash-in-place (WIP) design systems.

 “They key to success for implementing an integrated CIP or WIP system is to plan, design, execute, and test,” said Tim Hoover, business development manager, pharmaceutical/biotech at Niro Inc. (Columbia, MD, www.niroinc.com). A review of CIP and WIP processes, design, and validation issues were part of a presentation titled “Advances in the Integration of CIP/WIP in Solid Dosage Manufacturing” during Wednesday’s session of Interphex2007 Conference and Exhibition.

Hoover emphasized the importance of incorporating temperature, action (mechanical engineering), chemicals (commonly known at TACT), and time in controllable CIP parameters. Although automated CIP processes are higher in cost and have more complex designs, many companies have chosen to implement these systems because they enable the practical use of programmable logic controllers, which means they are reliable and repeatable and reduce the dependence of manual standard operating procedures, noted Hoover. In addition, automated CIP systems reduced the chance of a sterility breach.

One of the most common applications of CIP is for process tanks, a task that presents several challenges. “A tank is never easy to clean because it often has domes, shadow areas, or sumps. Therefore, one spray device often is not enough to clean a tank,” say Hoover.

There are several CIP devices, with spray balls being the most common. The advantages of spray balls are that they are simple, inexpensive, have no moving parts, small, and require low pressure feeds (approximately 2 bar). The disadvantages include that high CIP supply volumes are required and they are easily blocked.

However, implementing a CIP design takes a lot of upfront consideration. “A CIP design are not add on,” said Hoover. “They need to be considered and incorporated from day one. This includes cleanability audits of equipment, interconnect ducts, and so forth. CIP circuits need to be designed with the process, not as an after-thought.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: INTERPHEX Show Daily,
Click here